Executive Summary
Wabtec has filed an IPR petition challenging Railware’s RE 47835 patent covering railway block‑and‑unblock code systems. The petition asserts obviousness over the FRA‑Report and several secret‑code references.
Related Cases
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB has instituted an inter partes review of Inari Medical’s hemostasis valve patent after finding Imperative Care’s likelihood of success sufficient. All nine claims are now under trial.
SAP America, Inc. et al.vsValtrus Innovations Ltd.
SAP America seeks an IPR on Valtrus’s 6,889,244 patent covering fault‑tolerant messaging, arguing the claims are obvious over Bowman, Vahalia and Tuxedo. The petition also opposes discretionary denial under §§ 325(d) and 314(a).
Comcast Corporation et al.vsEntropic Communications LLC
Comcast challenges Entropic's '518 patent, arguing that the multi-carrier modulation and bit-loading technology is obvious under 35 U.S.C. § 103. The petitioner asserts that prior art references (Afshary, Mirfakhraei, Welles) combine to render all four claimed methods unpatentable.
Abbott Laboratories et al.vsMIRACOR MEDICAL SA
Abbott Laboratories challenged MIRACOR MEDICAL SA's heart assist pump patent (11754077) on grounds of obviousness over Wampler and Bourque. The PTAB instituted the IPR, affirming plain meanings for key terms like 'magneto coupling,' while finding Petitioner's rationale persuasive regarding combination art.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
Samsung successfully challenged claim 16 of Netlist’s ’912 memory‑module patent, with the PTAB finding the claim obvious over the Ellsberry reference and unpatentable.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.